Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Rybelsus 3mg Tablet
Manufacturer/Marketed By : NOVO NORDISK INDIA PVT LTD
$31.65 $26.91
Rybelsus 3mg tablet contains active components such as Semaglutide. This medication belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). This medication treats type 2 diabetes...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
SEMAGLUTIDE
Active Pharmaceutical Ingredient
Rybelsus 3mg Tablet
$31.65
$26.91
Rybelsus 3mg tablet contains active components such as Semaglutide. This medication belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). This medication treats type 2 diabetes by lowering blood sugar levels and promoting weight loss. It also reduces the risk of cardiovascular events in high-risk diabetes patients. It can be combined with other diabetes medications for better control and may lower blood pressure, benefitting cardiovascular health. Additionally, it shows potential in protecting kidneys and slowing diabetic kidney disease progression. You should not take Rybelsus 3mg tablet if you have a known hypersensitivity to this medication or any of its components. People with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not take this medication. It is not approved for use in pediatric patients with type 2 diabetes. It should not used in individuals with a history of severe gastrointestinal disease, such as gastroparesis. This medication is not recommended for individuals with severe renal impairment or end-stage renal disease. Rybelsus 3 mg price varies by retailer and location. You can buy Rybelsus 3mg online at MrMed For Affordable Prices.
Active Pharmaceutical Ingredient
Uses
• Type 2 diabetes mellitus
• Obesity or overweight.
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Rybelsus 3 mg side effects, like all medications, may occur in some people, although not everyone will experience them.
Most Common Side Effects
• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Decreased appetite
• Headache
• Fatigue
• Injection site reactions (e.g., redness, pain, itching)
Common Side Effects
• Allergic reactions
• Pancreatitis (abdominal pain, nausea, vomiting)
• Hypoglycemia (low blood sugar)
• Kidney problems (changes in urination, swelling in the ankles or feet)
• Thyroid C-cell tumors
How To Use
Rybelsus 3mg tablet is typically administered as a subcutaneous injection. The injection can be given in the abdomen, thigh, or upper arm. These medication pens come with clear instructions on how to load the needle, dial the dose, and administer the injection. After injecting, dispose of the needle safely in a sharps container. Regular monitoring and follow-up with your healthcare provider are important to assess your progress and make any dosage adjustments to your treatment plan.
Safety Advice
• Breast Feeding: If you are breastfeeding, consult your healthcare provider before using Rybelsus 3mg tablet, as its efficacy and safety in breastfeeding are unknown.
• Alcohol: Alcohol can affect blood sugar levels and potentially interfere with diabetes management. Consult your healthcare provider regarding alcohol consumption while using Rybelsus 3mg tablet.
• Liver: Rybelsus 3mg tablet should be used cautiously in individuals with severe liver disease. If you have any lung or liver conditions, discuss the risks and benefits of Rybelsus 3mg tablet with your healthcare provider before starting treatment.
• Lungs: Rybelsus 3mg tablet should be used cautiously in individuals with severe lung disease. If you have any lung or lung conditions, discuss the risks and benefits of Rybelsus 3mg tablet with your healthcare provider before starting treatment.
• Driving: Rybelsus 3mg tablet is not known to cause drowsiness or impair cognitive function. However, if you experience any side effects that may affect your ability to drive or operate machinery, such as dizziness or hypoglycemia (low blood sugar), use caution and consult your doctor.
• Pregnancy: Rybelsus 3mg tablet is not recommended if you are pregnant or planning to become pregnant, consult your healthcare provider before using it.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.